As a Free StocksGuide user, you can view scores for all 7,040 stocks worldwide.
15 Analysts have issued a Fisher & Paykel Healthcare forecast:
15 Analysts have issued a Fisher & Paykel Healthcare forecast:
| Mar '25 |
+/-
%
|
||
| Revenue | 2,021 2,021 |
16%
16%
|
|
| Gross Profit | 1,271 1,271 |
22%
22%
|
|
| EBITDA | - - |
-
|
|
| EBIT (Operating Income) EBIT | 510 510 |
44%
44%
|
|
| Net Profit | 377 377 |
184%
184%
|
|
In millions NZD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Fisher & Paykel Healthcare Corp. Ltd. engages in the design, manufacture, and marketing of products and systems for use in acute and chronic respiratory care, surgery, and treatment of obstructive sleep apnea. The firm provides medical device products and systems for use in both hospital and homecare settings. Its hospital product group includes products used in invasive ventilation, noninvasive ventilation, nasal high flow therapy, anesthesia, and laparoscopic and open surgery. Its homecare product group includes devices and systems used to treat obstructive sleep apnea (OSA) and provide respiratory support in the home, which include its continuous positive airway pressure (CPAP) therapy masks as well as flow generators, interfaces, and data management technologies. The Company’s products are sold in over 120 countries worldwide. The company operates across Canada, the United States of America, Mexico, Costa Rica, the United Kingdom, Switzerland, India, and others.
| Head office | New Zealand |
| Website | www.fphcare.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


